PT-141 (Bremelanotide)
PT-141, also known as Bremelanotide, is a synthetic cyclic heptapeptide analogue of alpha-MSH (alpha-Melanocyte-Stimulating Hormone) that acts as a melanocortin receptor agonist, specifically targeting MC3R and MC4R in the central nervous system. Unlike PDE5 inhibitors (e.g. sildenafil), PT-141 works centrally
through the brain's melanocortin system to stimulate sexual arousal and desire in both men and women. It is FDA-approved (as Vyleesi) for hypoactive sexual desire disorder (HSDD) in premenopausal women.
Choose your dosage
Purity: 99%
Form: Lyophilized Powder
Description
DEFINITION
PT-141, also known as Bremelanotide, is a synthetic cyclic heptapeptide analogue of alpha-MSH (alpha-Melanocyte-Stimulating Hormone) that acts as a melanocortin receptor agonist, specifically targeting MC3R and MC4R in the central nervous system. Unlike PDE5 inhibitors (e.g. sildenafil), PT-141 works centrally
through the brain's melanocortin system to stimulate sexual arousal and desire in both men and women. It is FDA-approved (as Vyleesi) for hypoactive sexual desire disorder (HSDD) in premenopausal women.
KEY BENEFITS
■Centrally acting sexual arousal stimulant — works via the brain, not vascular pathways
â– FDA-approved for hypoactive sexual desire disorder (HSDD) in women
â– Effective in men for erectile dysfunction, including cases unresponsive to PDE5 inhibitors
â– Enhances libido and sexual motivation in both men and women
â– May improve mood and energy via melanocortin receptor activation
Available Quantities
10mg
All products are sold for research and laboratory use only.
